Evidence map›Paper›PMID 32466184›Full record

ArticleCancers2020

A Machine-learning Approach for the Assessment of the Proliferative Compartment of Solid Tumors on Hematoxylin-Eosin-Stained Sections.

Francesco Martino, Silvia Varricchio, Daniela Russo, Francesco Merolla, Gennaro Ilardi, Massimo Mascolo, Giovanni Orabona dell'Aversana, Luigi Califano, Guglielmo Toscano, Giuseppe De Pietro and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. QuPath: The global impact of an open source digital pathology system.Computational and structural biotechnology journal · 2021
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Francesco MartinoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-8906-120X
Silvia VarricchioDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, 80131 Naples, Italy.
Daniela RussoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, 80131 Naples, Italy.
Francesco MerollaDepartment of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.
Gennaro IlardiDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, 80131 Naples, Italy.
Massimo MascoloDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, 80131 Naples, Italy.
Giovanni Orabona dell'AversanaDepartment of Maxillofacial Surgery, University of Naples "Federico II", 80131 Naples, Italy.
Luigi CalifanoDepartment of Maxillofacial Surgery, University of Naples "Federico II", 80131 Naples, Italy.
Guglielmo ToscanoHealthcare Informatics Services, A.O.U. Federico II, 80131 Naples, Italy.
Giuseppe De PietroInstitute for High Performance Computing and Networking of National Research Council of Italy, ICAR-CNR.ORCID 0000-0002-4675-5957
Maria FrucciInstitute for High Performance Computing and Networking of National Research Council of Italy, ICAR-CNR.
Nadia BrancatiInstitute for High Performance Computing and Networking of National Research Council of Italy, ICAR-CNR.
Filippo FraggettaPathology Unit, Azienda Ospedaliera per l'Emergenza Cannizzaro Hospital, 95126 Catania, Italy.
Stefania StaibanoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, 80131 Naples, Italy.
University of Naples Federico II · ITInstitute for High Performance Computing and Networking · ITOspedale Cannizzaro · ITUniversity of Molise · IT

Funding

POR Campania FESR 2014-2020 PG/2017/0623667
6 · The paper itself

Abstract

We introduce a machine learning-based analysis to predict the immunohistochemical (IHC) labeling index for the cell proliferation marker Ki67/MIB1 on cancer tissues based on morphometrical features extracted from hematoxylin and eosin (H&E)-stained formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples. We provided a proof-of-concept prediction of the Ki67/MIB1 IHC positivity of cancer cells through the definition and quantitation of single nuclear features. In the first instance, we set our digital framework on Ki67/MIB1-stained OSCC (oral squamous cell carcinoma) tissue sample whole slide images, using QuPath as a working platform and its integrated algorithms, and we built a classifier in order to distinguish tumor and stroma classes and, within them, Ki67-positive and Ki67-negative cells; then, we sorted the morphometric features of tumor cells related to their Ki67 IHC status. Among the evaluated features, nuclear hematoxylin mean optical density (NHMOD) presented as the best one to distinguish Ki67/MIB1 positive from negative cells. We confirmed our findings in a single-cell level analysis of H&E staining on Ki67-immunostained/H&E-decolored tissue samples. Finally, we tested our digital framework on a case series of oral squamous cell carcinomas (OSCC), arranged in tissue microarrays; we selected two consecutive sections of each OSCC FFPE TMA (tissue microarray) block, respectively stained with H&E and immuno-stained for Ki67/MIB1. We automatically detected tumor cells in H&E slides and generated a "false color map" (FCM) based on NHMOD through the QuPath measurements map tool. FCM nearly coincided with the actual immunohistochemical result, allowing the prediction of Ki67/MIB1 positive cells in a direct visual fashion. Our proposed approach provides the pathologist with a fast method of identifying the proliferating compartment of the tumor through a quantitative assessment of the nuclear features on H&E slides, readily appreciable by visual inspection. Although this technique needs to be fine-tuned and tested on larger series of tumors, the digital analysis approach appears to be a promising tool to quickly forecast the tumor's proliferation fraction directly on routinely H&E-stained digital sections.

Indexed as

digital pathologyKi67machine learning

Identifiers

PMID32466184
PMCPMC7281627
OpenAlexW3026524370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.